K841407 is an FDA 510(k) clearance for the ISOGEL AGAROSE. Classified as Apparatus, Electrophoresis, For Clinical Use (product code JJN), Class I - General Controls.
Submitted by Fmc Corp. (Walker, US). The FDA issued a Cleared decision on July 16, 1985 after a review of 468 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.2485 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.
View all Fmc Corp. devices